financetom
Business
financetom
/
Business
/
BRIEF-Crown Laboratories And Revance Announce Entry Into Merger Agreement
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-Crown Laboratories And Revance Announce Entry Into Merger Agreement
Aug 12, 2024 6:27 AM

Aug 12 (Reuters) - Revance Therapeutics Inc ( RVNC ):

* CROWN LABORATORIES AND REVANCE ANNOUNCE ENTRY INTO MERGER

AGREEMENT

* CROWN TO ACQUIRE REVANCE FOR $6.66 PER SHARE IN CASH

* PROPOSED DEAL FOR TOTAL ENTERPRISE VALUE OF $924 MILLION

* AFTER DEAL, CO'S STOCK WILL NO LONGER BE PUBLICLY TRADED

ON

NASDAQ

Source text for Eikon:

Further company coverage:

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
In surprise twist, Armani's will instructs heirs to gradually sell fashion brand or seek listing
In surprise twist, Armani's will instructs heirs to gradually sell fashion brand or seek listing
Sep 12, 2025
MILAN (Reuters) - Late designer Giorgio Armani has instructed heirs to gradually sell the fashion brand he created 50 years ago or seek a stock market listing, his will said, marking a surprising turn for a company highly protective of its independence and Italian roots. The will, reviewed by Reuters, states heirs should sell an initial 15% stake in the...
Update: RH Fiscal Q2 Adjusted Earnings, Sales Miss; Cuts 2025 Revenue Growth Outlook; Shares Drop Premarket
Update: RH Fiscal Q2 Adjusted Earnings, Sales Miss; Cuts 2025 Revenue Growth Outlook; Shares Drop Premarket
Sep 12, 2025
05:04 AM EDT, 09/12/2025 (MT Newswires) -- (Updates with the stock move in the headline and the first paragraph.) RH (RH) shares were down over 8% in recent premarket activity Friday after the company overnight reported Q2 net income and sales below market expectations, and also lowered its revenue growth outlook for fiscal 2025. The company reported fiscal Q2 adjusted...
Chinese insur-tech platform Huize Q2 revenue up 40.2%, returns to profit
Chinese insur-tech platform Huize Q2 revenue up 40.2%, returns to profit
Sep 12, 2025
Overview * Huize ( HUIZ ) Q2 revenue grows 40.2% to RMB 396.7 mln ($55.4 mln), driven by increased first-year premiums * Company reports Q2 net profit of RMB 10.9 mln, reversing last year's net loss * First-year premiums surge 73.1% yr/yr, boosting overall business performance Outlook * Company focuses on AI integration to enhance efficiency and service quality Result...
Form 8.3 - Spirent Communications PLC
Form 8.3 - Spirent Communications PLC
Sep 12, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved